Predict your next investment

Apricus Biosciences company logo
Corporation
HEALTHCARE | Pharmaceuticals / Drugs
apricusbio.com

See what CB Insights has to offer

Partners & Customers

10

About Apricus Biosciences

Apricus Biosciences is a pharmaceutical company that has leveraged the flexibility of clinically-validated NexACT drug delivery technology to enable multi-route administration of new and improved compound. In addition, the company is seeking to monetize its existing product pipeline, including its first product, Vitaros, approved in Canada for the treatment of erectile dysfunction and compounds in development from pre-clinical through Phase III, focused on Sexual Dysfunction, Oncology, Dermatology, Autoimmune, Pain, Anti-Infectives, Diabetes and Cosmeceuticals among others.

Apricus Biosciences Headquarter Location

11975 El Camino Real Suite 300

San Diego, California, 92130,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Apricus Biosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Apricus Biosciences in 2 Expert Collections, including Diabetes.

D

Diabetes

1,750 items

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

Latest Apricus Biosciences News

Arousal Disorder Treatment Market to Witness High Growth in Near Future By Top Manufactures: Apricus Biosciences, Inc., Merck & Co., Inc., Cipla Inc., Novo Nordisk India Pvt Ltd

Aug 11, 2021

Search jobs 11-Aug-2021 Arousal Disorder Treatment Market to Witness High Growth in Near Future By Top Manufactures: Apricus Biosciences, Inc., Merck & Co., Inc., Cipla Inc., Novo Nordisk India Pvt Ltd The Arousal Disorder Treatment Market Report conveys the clean expounded structure of the Market including every single business-related data of the market at a worldwide level. The total scope of data identified with the Market is acquired through different sources and this got main part of the data is orchestrated, handled, and spoken to by a gathering of authorities through the utilization of various methodological procedures and logical instruments, for example, SWOT analysis to produce an entire arrangement of exchange based examination in regards to the Arousal Disorder Treatment Market. Arousal disorder treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. The rising prevalence of chronic diseases and emerging markets are the factors responsible for the growth of the arousal disorder treatment market. Download Free Sample Copy of the Report to Understand the Structure of the Complete Report (Including Full TOC, Table & Figures) @  https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-arousal-disorder-treatment-market Prominent Key Players – Covered in the report:  Apricus Biosciences, Inc., Merck & Co., Inc., Cipla Inc., Novo Nordisk India Pvt Ltd, Sprout Pharmaceuticals, Inc., Emotional Brain BV, Duchesnay Inc., AMAG Pharmaceuticals among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. …. Female sexual arousal disorder arises when the body is not responding to sexual stimulation. It used to be called a territory of its own. Doctors viewed this differently from the hypoactive condition of sexual appetite which has to do with a lack of desire for sexual activity. Attributable to the widespread adoption of unhealthy lifestyle results in  hormonal imbalance , which further results in arousal disorder. Psychological or physical conditions such as heart attacks and neurological diseases are the primary reason behind the arousal disorder. Furthermore, conditions such as hormonal imbalance,  diabetes , renal failure, liver disorder, substance addiction, alcoholism and others also contribute to arousal disorder. Thus, these are the factors driving the arousal disorder treatment market growth in the above mentioned forecast period. Lack of knowledge of sexual issues and their proper diagnosis, especially in developing nations, can hamper the arousal disorder treatment market growth. The research & development activities, favourable government and regulatory policies, increasing challenges particularly in developing regions are acting as major opportunities for the arousal disorder treatment market growth. This arousal disorder treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info arousal disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. Global Arousal Disorder Treatment Market Scope and Market Size The arousal disorder treatment market is segmented on the basis of type, treatment, end-users and distribution channel. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target markets. On the basis of type, the arousal disorder treatment market is segmented into arousal disorder, penetration disorder, and female orgasmic disorder. On the basis of treatment, the arousal disorder treatment market is segmented into  hormone therapy , and changing medication dosage. On the basis of end-users, the arousal disorder treatment market is segmented into  hospitals , specialty clinics and others. On the basis of distribution channel, the arousal disorder treatment market has also been segmented into hospital pharmacy, retail pharmacy others. Highlights of the Report? The report offers a 360-degree overview of the market and emphasizes significant factors promoting, repelling, challenging, and creating opportunities for the market in the forecast duration. The report also lists the names of key players operating in the market and the strategies adopted by them to earn the lion’s share in the market. It also offers interesting insights into the market, current Arousal Disorder Treatment market trends, and major industry developments of the market. The report also discusses the table of segmentation in detail and lists the names of the leading segment with its attributed factors. It is available for sale on the company website. Market Segment by Regions: Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Arousal Disorder Treatment Market is framed with a bunch of Graphical Statistics, Table and Figures, Data Analysis Representation described in detail with a clear goal to target potential company stakeholders. Including Industry Chain Structure strongly gives out the overview of market growth and it becomes easy to project the hurdles and upsurge profit graphs. Coming to the Competitive landscape this Arousal Disorder Treatment Market report gives out each and every aspect required to size the existing market performance including technological advancements, business overview, positive and negative factors of market position and challenges faced but the market leaders to rank themselves above all. Quality parameters like Arousal Disorder Treatment sales reach, regional coverage, production price trends, and manufacturing cost structure are also studied to give out a perfect competition outlook. How Does This Market Insights Help? Arousal Disorder Treatment Market share (regional, product, application, end-user) both in terms of volume and revenue along with CAGR Key factors which are driving this market and restraining its growth What all challenges manufacturers will face as well as new opportunities and threats faced by them Learn about the market strategies that are being adopted by your competitors and leading organizations To gain insightful analyses of the market and have a comprehensive understanding of the “Arousal Disorder Treatment Market” and its commercial landscape Get Table Of Contents of This Premium Research For Free:  https://www.databridgemarketresearch.com/toc/?dbmr=global-arousal-disorder-treatment-market Major Key Contents Covered in Arousal Disorder Treatment Market: Introduction of Arousal Disorder Treatment with development and status. Manufacturing Technology of Arousal Disorder Treatment with analysis and trends. Analysis of Global Arousal Disorder Treatment market Key Manufacturers with Company Profile, Product Information, Production Information, and Contact Information. Analysis of Global Arousal Disorder Treatment market Capacity, Production, Production Value, Cost and Profit Analysis Arousal Disorder Treatment Market with Comparison, Supply, Consumption, and Import and Export. Arousal Disorder Treatment market Analysis with Market Status and Market Competition by Companies and Countries. Market Forecast of Global Arousal Disorder Treatment Market with Cost, Profit, Market Shares, Supply, Demands, Import and Export. Trending factors influencing the market shares of APAC, Europe, North America, and ROW? Arousal Disorder Treatment Market Analysis of Industry Chain Structure, Upstream Raw Materials, Downstream Industry. Reasons to Purchase this Report Current and future of global Arousal Disorder Treatment market outlook in the developed and emerging markets The segment that is expected to dominate the market as well as the segment which holds the highest CAGR in the forecast period Regions that are expected to witness the fastest growth rates during the forecast period The latest development, market shares and strategies that are working by the major market players A complete value chain of the global Arousal Disorder Treatment market is presented in the research report. It is associated with the review of the downstream and upstream components of the Arousal Disorder Treatment Market. The market is split on the basis of the categories of products and client application segments. The market analysis demonstrates the expansion of each segment of the global Arousal Disorder Treatment market. The research report assists the user in taking a decisive step on the way to be a milestone in growing and expanding their organizations inside the worldwide Arousal Disorder Treatment market. Some of the Major Highlights of TOC cover: Chapter 1: Methodology & Scope Industry segmentation SWOT Analysis In conclusion, the Arousal Disorder Treatment Market report is a reliable source for accessing the research data that is projected to exponentially accelerate your business. The report Give information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis is also incorporated in the report along with speculation attainability inspection and venture return investigation. For More Information or Query or Customization before Buying, Visit at:  https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-arousal-disorder-treatment-market Customization of the Report: Data Bridge Market Research also provides customization options to tailor the reports as per client requirements. This report can be personalized to cater to your research needs. Feel free to get in touch with our sales team, who will ensure that you get a report as per your needs. Thank you for reading this article. You can also get chapter-wise sections or region-wise report coverage for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. About Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rates Editor Details

Apricus Biosciences Acquisitions

2 Acquisitions

Apricus Biosciences acquired 2 companies. Their latest acquisition was Seelos Therapeutics on July 30, 2018.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

7/30/2018

$99M

Reverse Merger

3

12/30/2011

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/30/2018

12/30/2011

Investment Stage

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

Note

Reverse Merger

Subscribe to see more

Sources

3

10

Apricus Biosciences Partners & Customers

10 Partners and customers

Apricus Biosciences has 10 strategic partners and customers. Apricus Biosciences recently partnered with Ferring Pharmaceuticals on March 3, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

3/10/2017

Partner

Switzerland

Ferring acquires ex-U.S. assets and rights for Vitaros® (alprostadil cream), Apricus’ on-demand topical cream for erectile dysfunction - Ferring Corporate Website

Saint-Prex , Switzerland -- 09 March 2017 -- Ferring Pharmaceuticals today announced an agreement with Apricus Biosciences , Inc. , granting Ferring Pharmaceuticals global assets and rights , excluding the U.S. , related to Apricus Biosciences , Inc. ' Vitaros ® .

1

8/4/2016

Licensee

Switzerland

Richard W. Pascoe.

, if any ; Apricus Biosciences , Inc. ' plans for life-cycle development programs for Vitaros ; Apricus Biosciences , Inc. ' development and partnering plans for RayVa ; Apricus Biosciences , Inc. ' plans to pursue out-licensing opportunities for Vitaros in .

6

4/6/2016

Partner

United States

Rationalize the Development Pipeline.

, if any ; Apricus Biosciences , Inc. ' plans for life-cycle development programs for Vitaros ; Apricus Biosciences , Inc. ' development and partnering plans for RayVa ; and Apricus Biosciences , Inc. ' plans to streamline the Company , reduce operating expenses and achieve profitability .

1

10/1/2015

Partner

Switzerland

Subscribe to see more

Subscribe to see more

10

8/8/2014

Partner

United States

Subscribe to see more

Subscribe to see more

10

Date

3/10/2017

8/4/2016

4/6/2016

10/1/2015

8/8/2014

Type

Partner

Licensee

Partner

Partner

Partner

Business Partner

Country

Switzerland

Switzerland

United States

Switzerland

United States

News Snippet

Ferring acquires ex-U.S. assets and rights for Vitaros® (alprostadil cream), Apricus’ on-demand topical cream for erectile dysfunction - Ferring Corporate Website

Saint-Prex , Switzerland -- 09 March 2017 -- Ferring Pharmaceuticals today announced an agreement with Apricus Biosciences , Inc. , granting Ferring Pharmaceuticals global assets and rights , excluding the U.S. , related to Apricus Biosciences , Inc. ' Vitaros ® .

Richard W. Pascoe.

, if any ; Apricus Biosciences , Inc. ' plans for life-cycle development programs for Vitaros ; Apricus Biosciences , Inc. ' development and partnering plans for RayVa ; Apricus Biosciences , Inc. ' plans to pursue out-licensing opportunities for Vitaros in .

Rationalize the Development Pipeline.

, if any ; Apricus Biosciences , Inc. ' plans for life-cycle development programs for Vitaros ; Apricus Biosciences , Inc. ' development and partnering plans for RayVa ; and Apricus Biosciences , Inc. ' plans to streamline the Company , reduce operating expenses and achieve profitability .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

6

1

10

10

Apricus Biosciences Team

2 Team Members

Apricus Biosciences has 2 team members, including former Chief Financial Officer, Senior Vice President, Steve Martin.

Name

Work History

Title

Status

Steve Martin

Chief Financial Officer, Senior Vice President

Former

Brian T. Dorsey

Senior Vice President

Former

Name

Steve Martin

Brian T. Dorsey

Work History

Title

Chief Financial Officer, Senior Vice President

Senior Vice President

Status

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.